Details of the Drug

General Information of Drug (ID: DMCIAJL)

Drug Name
N-hydroxy-nor-L-arginine
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 176.17
Logarithm of the Partition Coefficient (xlogp) -4.6
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 5
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C5H12N4O3
IUPAC Name
(2S)-2-amino-4-[[amino-(hydroxyamino)methylidene]amino]butanoic acid
Canonical SMILES
C(CN=C(N)NO)[C@@H](C(=O)O)N
InChI
InChI=1S/C5H12N4O3/c6-3(4(10)11)1-2-8-5(7)9-12/h3,12H,1-2,6H2,(H,10,11)(H3,7,8,9)/t3-/m0/s1
InChIKey
KOBHCUDVWOTEKO-VKHMYHEASA-N
Cross-matching ID
PubChem CID
446124
ChEBI ID
CHEMBL1234777
CAS Number
189302-40-7
UNII
U0F1149OFR
DrugBank ID
DB02381
TTD ID
D09ZIC
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Kidney-type arginase (ARG2) TTV1AG6 ARGI2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation. 2003 Oct 21;108(16):2000-6.